| Genome-wide association analyses identify 18 new loci associated with serum urate concentrations A Köttgen, E Albrecht, A Teumer, V Vitart, J Krumsiek, C Hundertmark, ... Nature genetics 45 (2), 145-154, 2013 | 507 | 2013 |
| Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function MS Artigas, DW Loth, LV Wain, SA Gharib, M Obeidat, W Tang, G Zhai, ... Nature genetics 43 (11), 1082-1090, 2011 | 479 | 2011 |
| Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized … S Rögnvaldsson, TJ Love, S Thorsteinsdottir, ER Reed, JÞ Óskarsson, ... Blood Cancer Journal 11 (5), 94, 2021 | 67 | 2021 |
| Modulation of genetic associations with serum urate levels by body-mass-index in humans JE Huffman, E Albrecht, A Teumer, M Mangino, K Kapur, T Johnson, ... PloS one 10 (3), e0119752, 2015 | 46 | 2015 |
| Fractures and survival in multiple myeloma: results from a population-based study S Thorsteinsdottir, G Gislason, T Aspelund, I Sverrisdottir, O Landgren, ... Haematologica 105 (4), 1067, 2020 | 42 | 2020 |
| Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: results of the iStopMM study TE Long, OS Indridason, R Palsson, S Rognvaldsson, TJ Love, ... Blood Cancer Journal 12 (9), 133, 2022 | 39 | 2022 |
| Prevalence of smoldering multiple myeloma based on nationwide screening S Thorsteinsdóttir, GK Gíslason, T Aspelund, S Rögnvaldsson, ... Nature medicine 29 (2), 467-472, 2023 | 26 | 2023 |
| Comorbidities in multiple myeloma and implications on survival: A population‐based study IS Sverrisdóttir, S Rögnvaldsson, S Thorsteinsdottir, GK Gíslason, ... European journal of haematology 106 (6), 774-782, 2021 | 22 | 2021 |
| Screening for monoclonal gammopathy of undetermined significance: a population-based randomized clinical trial. First results from the Iceland Screens, Treats, or Prevents … SY Kristinsson, S Rögnvaldsson, S Thorsteinsdottir, ER Reed, ... Blood 138, 156, 2021 | 17 | 2021 |
| Prevalence of MGUS is high in the istopmm study but the prevalence of IgA MGUS does not increase with age in the way other immunoglobulin subtypes do TJ Love, S Rögnvaldsson, S Thorsteinsdottir, T Aspelund, ER Reed, ... Blood 140 (Supplement 1), 256-258, 2022 | 9 | 2022 |
| Autoimmune disease is associated with a lower risk of progression in monoclonal gammopathy of undetermined significance TR Baldursdóttir, ÞJ Löve, GK Gíslason, M Björkholm, UH Mellqvist, ... European journal of haematology 106 (3), 380-388, 2021 | 9 | 2021 |
| Prevalence of smoldering multiple myeloma: results from the Iceland Screens, Treats, or Prevents Multiple Myeloma (iStopMM) study S Thorsteinsdottir, GK Gislason, T Aspelund, S Rögnvaldsson, ... Blood 138 (Supplement 1), 151-151, 2021 | 8 | 2021 |
| Monoclonal gammopathy of undetermined significance and COVID-19: a population-based cohort study S Rognvaldsson, E Eythorsson, S Thorsteinsdottir, B Vidarsson, ... Blood Cancer Journal 11 (12), 191, 2021 | 7 | 2021 |
| Multiethnic genome-wide association study of subclinical atherosclerosis in individuals with type 2 diabetes Y Lu, L Dimitrov, SH Chen, LF Bielak, JC Bis, MF Feitosa, L Lu, M Kavousi, ... Circulation: Genomic and Precision Medicine 14 (4), e003258, 2021 | 7 | 2021 |
| A nationwide study on inpatient opportunistic infections in patients with chronic lymphocytic leukemia in the pre‐ibrutinib era V Steingrímsson, GK Gíslason, S Þorsteinsdóttir, S Rögnvaldsson, ... European journal of haematology 106 (3), 346-353, 2021 | 7 | 2021 |
| Disease associations with monoclonal gammopathy of undetermined significance can only be evaluated using screened cohorts: results from the population-based iStopMM study AÝ Sigurbergsdóttir, S Rögnvaldsson, S Thorsteinsdóttir, I Sverrisdóttir, ... Haematologica 108 (12), 3392, 2023 | 5 | 2023 |
| The first wave of COVID‐19 and concurrent social restrictions were not associated with a negative impact on mental health and psychiatric well‐being TJ Love, I Wessman, GK Gislason, S Rognvaldsson, S Thorsteinsdottir, ... Journal of Internal Medicine 291 (6), 837-848, 2022 | 5 | 2022 |
| Autoimmune diseases are not associated with monoclonal gammopathy of undetermined significance: results of the prospective population-based Istopmm study IS Sverrisdottir, S Thorsteinsdóttir, S Rögnvaldsson, T Aspelund, ... Blood 140 (Supplement 1), 10031-10032, 2022 | 4 | 2022 |
| Defining new reference intervals for serum free light chains in individuals with reduced kidney function: results of the population-based on iceland screens treats or prevents … T Einarsson Long, OS Indridason, R Palsson, S Rögnvaldsson, TJ Love, ... Blood 138 (Supplement 1), 542-542, 2021 | 4 | 2021 |
| Revised Definition of Free Light Chains in Serum and Light Chain Monoclonal Gammopathy of Undetermined Significance: Results of the Istopmm Study TE Long, S Rögnvaldsson, S Thorsteinsdottir, I Sverrisdottir, E Eythorsson, ... Blood 142, 535, 2023 | 3 | 2023 |
